grant

Mechanisms of sex discrepancy in autoimmune disease: Regulation of the female-biased VGLL3 immune pathway

Organization UNIVERSITY OF MICHIGAN AT ANN ARBORLocation ANN ARBOR, UNITED STATESPosted 1 Aug 2021Deadline 31 Jul 2026
NIHUS FederalResearch GrantFY2025AddressAffectAmericanAutoimmune DiseasesAutoimmune StatusAutoimmunityAutomobile DrivingAwardBasal Transcription FactorBasal transcription factor genesBindingBiologicalCancer GenesCancer-Promoting GeneCell BodyCell Culture TechniquesCell IsolationCell NucleusCell Nucleus Active TransportCell SegregationCell SeparationCell Separation TechnologyCellsClinicalCommunitiesComplexCutaneousCytoplasmDangerousnessDataDedicationsDermatologyDevelopmentDevelopment PlansDevelopment and ResearchDiseaseDisorderDisproportionate number of femalesDisproportionate number of womenDisproportionately affects femalesDisproportionately affects womenDisproportionately impacts femalesDisproportionately impacts womenDisproportionately in femalesDisproportionately in womenEmbryonic Muscle CellsEnvironmentEquipmentEthicsExanthemExanthemaExpression SignatureFamilyFemaleFosteringFundingGender BiasGene Action RegulationGene Expression ProfileGene Expression RegulationGene RegulationGene Regulation ProcessGene TargetingGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGeneralized GrowthGenesGenetic TranscriptionGoalsGrantGrowthHumanHuman ResourcesImmuneImmune PrecipitationImmunesImmunologyImmunoprecipitationIncidenceInternationalInvestigationInvestigatorsKnowledgeLaboratoriesLeadershipLearningLupusLupus Erythematosus DisseminatusManpowerMass Photometry/Spectrum AnalysisMass SpectrometryMass SpectroscopyMass SpectrumMass Spectrum AnalysesMass Spectrum AnalysisMediatingMedicineMentorsMentorshipMiceMice MammalsMichiganModern ManMolecular InteractionMurineMusMuscle CellsMutant Strains MiceMyoblastsMyocytesNational Institutes of HealthNuclearNuclear TransportNucleocytoplasmic ShuttlingNucleusOncogenesPathway interactionsPatientsPhysiciansPositionPositioning AttributePrecursor Muscle CellsPredispositionProteinsProteomicsPublic HealthR & DR&DRNA ExpressionRashRegulationRegulatory PathwayResearchResearch DesignResearch PersonnelResearchersRoleSLEScientistSex BiasShort interfering RNASignal PathwaySkinSkin RashSmall Interfering RNAStudy TypeSusceptibilitySystemic Lupus ErythematosusSystemic Lupus ErythematousSystemic Lupus ErythmatosusSystems BiologyTestingTissue GrowthTrainingTranscriptionTranscription ActivatorTranscription CoactivatorTranscription Factor CoactivatorTranscription Factor Proto-OncogeneTranscription factor genesTranscriptional Activator/CoactivatorTransforming GenesTransgenic MiceTransgenic OrganismsTranslational ResearchTranslational ScienceUnited StatesUnited States National Institutes of HealthUniversitiesValidationWomanautoimmune conditionautoimmune disorderautoimmunity diseasebiologiccareercareer developmentcell culturecell culturescell sortingcell typecofactordevelopmentaldisseminated lupus erythematosusdrivingethicalfallsfemale biasfemale morbidityfemale predominancefemale preponderancegene expression patterngene expression signaturehuman diseasehuman modelimprovedin vivoinhibitorinnovateinnovationinnovativeinsightkeratinocyteknock-downknockdownlab developmentlaboratory developmentlecturerlupus-likemalemenmodel of humanmorbidity among femalesmorbidity among womenmorbidity in femalesmorbidity in womenmouse modelmouse mutantmurine modelnew drug targetnew drug treatmentsnew druggable targetnew drugsnew pharmacological therapeuticnew pharmacotherapy targetnew therapeutic targetnew therapeuticsnew therapynew therapy targetnext generation therapeuticsnovelnovel drug targetnovel drug treatmentsnovel druggable targetnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel pharmacotherapy targetnovel therapeutic targetnovel therapeuticsnovel therapynovel therapy targetnucleocytoplasmic transportontogenyoverexpressoverexpressionpathwaypersonnelpredominance in femalespredominance in womenpreventpreventingpublic health relevanceresearch and developmentsexsiRNAskillssocial rolestudy designsystemic autoimmune diseasesystemic autoimmune disordersystemic lupus erythematosistargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttherapeutic targettranscription factortranscriptional profiletranscriptional signaturetransgenictranslation researchtranslational investigationvalidationswomen's morbiditywomen's predominancewomen's preponderance
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY/ABSTRACT
An estimated 10% of Americans suffer from autoimmune disease, and the vast majority of those affected are

women. This application proposes a five-year mentored career development and research plan for a physician

scientist to establish a niche in the field of skin immunology focused on autoimmune diseases such as systemic

lupus erythematosus that disproportionately affect women. By investigating the biological mechanisms that lead

to this sex bias, the candidate seeks to find new avenues to treat and potentially prevent these devastating

diseases. The candidate has demonstrated commitment to research throughout her training and is poised for a

career in academic medicine. This award will facilitate the training required to achieve her long-term career goals:

(1) Establish herself as an independent investigator and national leader in academic dermatology, with a career

focused on cutaneous immunology, (2) Establish a programmatic line of funded research to improve

understanding of cutaneous immunology and identify new therapeutic targets in female-biased autoimmune

disease, and (3) Learn to provide dedicated mentorship to foster career development of trainees at all levels.

Career development plan: Through formal coursework, didactic seminars, and hands-on training from mentors

and their lab personnel, the candidate will attain the scientific and career development training needed to achieve

these goals. She proposes to acquire specific scientific skills in systems biology applications, mouse modeling

of complex human disease, and approaches for study of cutaneous and systemic immunology. Simultaneously,

she will pursue her career development goals of integrating with the scientific community, enhancing leadership

and mentoring skills, and acquiring practical skills for the ethical conduct of translational research.

Environment: The candidate is a clinical lecturer at the University of Michigan working in the cutaneous

immunology laboratory of Dr. Johann Gudjonsson. She plans to expand her mentorship circle through this grant

to include international experts on lupus and mouse models of human disease. She has ample access to state-

of-the-art facilities and equipment, hands-on training and guidance from other physician scientist mentors, and

strong support for career and laboratory development from the Department of Dermatology.

Research design: The proposed scientific aims will foster the candidate's career development goals while

determining how the female-biased factor VGLL3 drives autoimmune disease in the skin of women. AIM 1 will

define how VGLL3 interacts with transcription factors to promote autoimmunity by integrating human cell culture

and transgenic mouse studies with a systems biology approach. AIM 2 will use proteomics data and validation

by siRNA-mediated knockdown to identify factors governing VGLL3 activity in human skin cells from patients of

both sexes with and without lupus. AIM 3 will determine how VGLL3 interfaces with the oncogene YAP in driving

autoimmunity and test a potential therapy in lupus patient skin cells and mice with lupus-like disease.

Grant Number: 5K08AR078251-05
NIH Institute/Center: NIH

Principal Investigator: Allison Billi

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →